drugset / Trial / NCT05070650

Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of Common Cold

NCT05070650

Phase 3 Withdrawn Sandoz
RandomizedParallel-groupDouble-blindTreatment

Summary

Prospective, randomized, multinational, multicenter, double-blind trial in 2 parallel groups of patients

Timeline

Start
2024-09-20
Primary completion
2025-04-30
Completion
2025-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 500 mg Oral
Subject N-acetylcysteine Small molecule 200 mg Oral
Subject Phenylephrine Small molecule 10 mg Oral

Indications